Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review

Reports of immune-related adverse events caused by programmed cell death-ligand 1 (PD-L1) inhibitor have been emerging. Herein, we report a subacute cutaneous lupus erythematosus (SCLE)-like eruption presented after the treatment of durvalumab in a patient with extensive-stage small cell lung carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratumchart, Nathathai, Chanprapaph, Kumutnart, Topibulpong, Nuttapong, Tankunakorn, Jutamas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763206/
https://www.ncbi.nlm.nih.gov/pubmed/35046689
http://dx.doi.org/10.2147/CCID.S344445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763206/
https://www.ncbi.nlm.nih.gov/pubmed/35046689
http://dx.doi.org/10.2147/CCID.S344445

Ejemplares similares